How Michael Pollan pivoted from agriculture to acid in new book


Michael Pollan knows you’re probably a little surprised to hear about his next book.

The author known for the seminal book “The Omnivore’s Dilemma” has been labeled a food writer, but he prefers thinking about himself as a nature writer.

Through that best-selling book and several others, including “Cooked” and “The Botany of Desire,” Pollan uses food, cooking, plants and agriculture as vehicles to dig into our relationship with nature, as well as the human psyche, culture and spirituality.

His new book does just that, but with a new lens: psychedelic drugs.

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence” doesn’t come out until May, but he’ll be in Austin this week for an event at the Long Center. He’ll chat with the Austin-based food activist Raj Patel about his path as a food writer and social activist and why he picked LSD and psilocybin mushrooms as his latest subjects.

This isn’t the first time Pollan has looked inquisitively into our connection with altered states. A chapter in “Cooked” is about fermentation, which includes booze, and why even animals get inebriated. In “The Botany of Desire,” he looked at marijuana through the lens of an evolutionary botanist and social historian.

It is with that same sense of curiosity that he approaches a substance known as lysergic acid diethylamide, which Timothy Leary famously championed in the 1960s as a chemical that could treat mental illness and lead to higher consciousness.

President Richard “Nixon had the sense that LSD was fueling the energies of the counterculture, and he was probably right,” Pollan said in a recent interview for “I Love You So Much: The Austin360 Podcast.” “You had a generation that was refusing to obey authority and go to war. He felt like the chemical bore some of that responsibility.”

The research support fell out for decades. But the question of whether psychedelics might be able to improve the lives of everyday people lingers, and only recently have U.S. researchers started to try to answer it. In England, researchers are already studying the effects of microdosing, when people take even smaller quantities to treat depression and anxiety and for end-of-life care.

One study that stuck with Pollan was conducted at Johns Hopkins, where they were giving psilocybin — the mushroom that has a similar effect as LSD but is shorter acting — to people who had life-changing diagnoses and who were struggling with anxiety and depression.

“The report said a great percentage of them felt that their fear of death had been substantially diminished, (but when one of the participants was asked directly) she corrected them: ‘My fear of death has not been diminished. My fear of death was eliminated.’”

When Pollan realized that someone’s total perspective on death could be reset during such a critical time in life, he knew the subject was worth pursuing. “There’s a powerful placebo or expectancy effect. If you think you’re going to have a bad trip, you probably will,” he says. “If you think it’s going to make you more creative, it probably will.”

As a proponent of immersing himself in his subject matter, Pollan says he took several guided psychedelic journeys, and he stresses the importance of a guide. “Every journey was different. I had one that was absolutely terrifying and would never want to repeat. I had others that were extended meditations about people in my life and helped me understand my parents and sisters in a way I hadn’t before.

“The most striking thing was to, for the first time, experiencing the complete dissolution of your sense of self or ego. Most of us think that we are the same as the ‘I’ chattering in our heads all the time, but it goes away in a high-dose psychedelic experience,” he says. “You kind of watch it vanish, and that can be very scary or it can be very liberating.”

With that distance, he gained a new perspective that sticks with him to this day. “Make no mistake — people do get into trouble taking these drugs, and they have terrifying experiences or accidents because they are not in control,” he says. “I feel a sense of responsibility when I talk about it to tell people about the risks involved, as well as the rewards.”



Reader Comments ...


Next Up in Insight and Books

Letters to the editor: May 21, 2018

Breakthrough! Refreshing news: President Trump’s lead lawyer says he wanted to have “the Hillary Clinton treatment” for the president. What a breakthrough for transparency. Clinton was treated to 11-plus hours of testimony to Congress, her files and servers turned over to the FBI, and Republican leaders asked the Justice Department...
Opinion: Trump breaks bread, glasses and party at lunch

POTUS coming to Tuesday lunch. Translated, the president of the United States is joining 50 Republican senators in the Capitol to crash their private Tuesday lunch. Nobody is glad to hear this on the Senate side. We love the constitutional separation of powers. The Senate is the last citadel of democracy, they say. We in the press are free as birds...
Opinion: Just saying yes to drug companies

Last week we learned that Novartis, the Swiss drug company, had paid Michael Cohen — Donald Trump’s personal lawyer — $1.2 million for what ended up being a single meeting. Then, on Friday, Trump announced a “plan” to reduce drug prices. Why the scare quotes? Because the “plan” was mostly free of substance...
Facebook comments: May 20, 2018
Facebook comments: May 20, 2018

In recent commentary the American-Statesman’s Bridget Grumet wrote about the uncertainty that those who receive federal housing aid are facing after Housing and Urban Development Secretary Ben Carson unveiled a proposal to raise the rents on millions of households who receive the assistance. “Be grateful for your good fortune if you don&rsquo...
Herman: Gubernatorial win for Valdez or White would be history-making
Herman: Gubernatorial win for Valdez or White would be history-making

Sometime Tuesday night the relatively few ballots will be tallied and we’ll bid a political farewell, possibly for all time, to one of the two contenders for the gubernatorial nomination of the once-great Democratic Party of Texas. The winner will advance to an upmountain (which is even steeper than uphill) battle with GOP Gov. Greg Abbott in...
More Stories